AIRT Form 4: Director sale of 20,103 shares; two 500-share options granted
Rhea-AI Filing Summary
Gary S. Kohler, a director of Air T Inc. (ticker AIRT), reported transactions dated 08/11/2025. He disposed of 20,103 shares of common stock and acquired two stock option awards of 500 shares each on the same date. The options have exercise prices of $30 and $50, become exercisable on 08/06/2026, and expire on 08/06/2045. Each option award covers 500 underlying shares and is reported as directly owned with a reported post-transaction beneficial ownership of 500 for each grant. The filing notes that previously granted unexercisable options from December 2020 are subject to price-tranche vesting and expirations and that, after prior expirations, 1,500 options remain outstanding. The form is signed and dated 08/14/2025.
Positive
- Receipt of long-dated option awards (500 shares at $30 and 500 shares at $50) which align insider pay with long-term share-price performance
- Clear disclosure of exercisability and expiration dates and explanation of prior contingent awards, enhancing transparency
Negative
- Disposal of 20,103 common shares by a director on 08/11/2025, a material near-term sale without stated rationale
- No indication in the filing that the sale was made under a 10b5-1 trading plan (box not marked), leaving intent unclear
Insights
TL;DR: Director sold a material block of shares while receiving long-dated, performance-linked options, signaling liquidity action but continued equity-based alignment.
The disposal of 20,103 common shares is a notable near-term liquidity event by an insider; the filing does not state proceeds or remaining share count for common stock holdings after the sale. Simultaneously, the director received two long-term option grants (500 shares at $30 and 500 shares at $50) exercisable in 2026 and expiring in 2045, which provide continued alignment with future share-price performance. The explanatory note about December 2020 tranches clarifies that some historic options are contingent on price thresholds and that 1,500 options remain outstanding after prior expirations. For investors, the mix of sale plus option grants is neutral-to-moderately informative regarding insider behavior but lacks context on total ownership levels.
TL;DR: The reported transactions reflect routine insider compensation and a separate share disposition; disclosure is complete for transaction mechanics but limited on intent.
The Form 4 properly discloses a director-level disposition and two option awards with detailed terms. The long exercise window and exercisable date indicate retention incentives rather than immediate liquidity from the awards. The filing also appropriately describes the conditional vesting mechanics of prior 2020 awards and the current outstanding option count of 1,500. The document does not provide rationale for the share sale or specify whether the sale was pursuant to a 10b5-1 plan; the box indicating a 10b5-1 sale is not marked in the provided content. From a governance perspective, the disclosure meets regulatory requirements but leaves open questions about timing and intent that would require supplementary company or insider commentary.